Logo for Denali Therapeutics Inc

Denali Therapeutics Investor Relations Material

Latest events

Logo for Denali Therapeutics Inc

Study Result

Denali Therapeutics
Logo for Denali Therapeutics

Q1 2025

6 May, 2025
Logo for Denali Therapeutics

Q4 2024

27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Denali Therapeutics Inc

Access all reports
Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company researches and creates treatments targeting conditions such as Alzheimer's disease, Parkinson’s disease, and other disorders affecting the central nervous system. Denali Therapeutics operates within the healthcare and biotechnology sectors. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.